Onyx Biotec Services IPO Details
| IPO Open Date: | November 13, 2024 |
| IPO Close Date: | November 18, 2024 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹58 to ₹61 Per Share |
| Issue Size: | Approx ₹29.34 Crores |
| Fresh Issue: | Approx ₹29.34 Crores |
| Offer for Sale: | Approx [.] Equity Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | NSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Onyx Biotec Services IPO Market Lot
The Onyx Biotec Services IPO minimum market lot is 2000 shares with ₹122,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 2,000 | ₹122,000 |
| Retail Maximum | 1 | 2,000 | ₹122,000 |
| HNI Minimum | 2 | 4,000 | ₹244,000 |
Onyx Biotec Services IPO Dates
The Onyx Biotec Services IPO date is November 13 and the close date is November 18. The Onyx Biotec Services IPO allotment will be finalized on November 19 and the IPO listing on November 21.
| IPO Open Date: | November 13, 2024 |
| IPO Close Date: | November 18, 2024 |
| Basis of Allotment: | November 19, 2024 |
| Refunds: | November 20, 2024 |
| Credit to Demat Account: | November 20, 2024 |
| IPO Listing Date: | November 21, 2024 |
Promoters of Onyx Biotec Services IPO
The promoters of the company are Sanjay Jain, Naresh Kumar and Fateh Pal Singh.
About Onyx Biotec Services IPO
On May 13, 2015, Onyx Biotech Limited began its operations in the pharmaceutical market, initially focusing on the supply of sterile water for injection. Over the years, Onyx has become a leading supplier of sterile pharmaceutical products, offering a variety of Dry Powder Injections and Dry Syrups for both domestic and international markets. The company is ranked among the top pharmaceutical companies in India, renowned for providing high-quality products at affordable prices without compromising on quality. Onyx Biotech has two manufacturing facilities, referred to as Unit I and Unit II. Unit I has the capacity to produce 638,889 units of Sterile Water for Injections daily in a single shift. In comparison, Unit II can manufacture 40,000 units of Dry Powder Injection and 26,667 units of Dry Syrup each day. At Onyx Biotech Limited, a dedicated team collaborates to create high-quality medicinal products that are accessible and affordable, ensuring that everyone can receive the treatment they need.
Onyx Biotec Services IPO Company Financial Report
The company reported revenue of ₹53.87 crores in 2024 against ₹39.62 crore in 2023. The company reported Profit of ₹3.03 crores in 2024 against Profit of ₹1.84 crores in 2023.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹44.98 | ₹41.19 | ₹3.35 | ₹36.84 |
| 2023 | ₹39.62 | ₹37.07 | ₹1.84 | ₹58.72 |
| 2024 | ₹53.87 | ₹49.82 | ₹3.03 | ₹74.14 |
| May 2024 | ₹10.54 | ₹8.79 | ₹1.31 | ₹74.77 |
Onyx Biotec Services IPO Valuation – FY2024
Check Onyx Biotec Services IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 10.58% |
| ROCE: | 12.19% |
| EBITDA Margin: | 15.41% |
| PAT Margin: | 5.64% |
| Debt to equity ratio: | 1.24 |
| Earning Per Share (EPS): | ₹2.54 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 12.19% |
| Net Asset Value (NAV): | ₹18.67 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Suven Pharma | 11.80 | 83.92 | 14.64 | 80.56 | 1,051.35 Cr. |
| JB Chemicals | 35.66 | 53.63 | 18.90 | 188.37 | 3,484.18 Cr. |
Objects of the Issue
- Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use;
- Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections;
- Prepayment or repayment of all or a portion of certain loans availed by the Company; and
- General Corporate Purposes.
Onyx Biotec Services IPO Review
- Canara Bank –
- DRChoksey FinServ –
- Emkay Global –
- Hem Securities –
- IDBI Capital –
- Marwadi Shares –
- Nirmal Bang –
- SBICAP Securities –
- Sharekhan –
- SMC Global –
- Sushil Finance –
- Swastika Investmart –
- Ventura Securities –
- Geojit –
- Reliance Securities –
- Capital Market –
- BP Wealth –
- ICICIdirect –
- Choice Broking –
Onyx Biotec Services IPO Registrar
Mas Services Limited
Phone: (011) 2610 4142
Email: [email protected]
Website: https://www.masserv.com/opt.asp
IPO Lead Managers aka Merchant Bankers
- Horizon Management Private Limited
Company Address
Onyx Biotec Limited
Bir Plassi Near Sainimajraropar,
Nalagarh Road
District Solan – 174101,
Phone: +91 172 265 6384
Email: [email protected]
Website: http://www.onyxbiotec.com/
Onyx Biotec Services IPO FAQs
What is Onyx Biotec Services IPO?
When Onyx Biotec Services IPO will open for subscription?
What is Onyx Biotec Services IPO Investors Portion?
How to Apply the Onyx Biotec Services IPO?
What is Onyx Biotec Services IPO Issue Size?
What is Onyx Biotec Services IPO Price Band?
What is Onyx Biotec Services IPO Lot Size?
What is the Onyx Biotec Services IPO Allotment Date?
What is the Onyx Biotec Services IPO Listing Date?
Note: The Onyx Biotec Services IPO price band and date are officially announced. The (Onyx Biotec Services IPO grey market premium) will be added to the IPO GMP page as it will start).
